Canadian application, no grantCanada
Use of 5-ht2 receptor antagonists for the treatment of sleep disorders
CA 2501082 A1 · Owner: Merck Patent Gmbh · Inventors: Van Amsterdam, Christoph; Bartoszyk, Gerd
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of 5-HT2 receptor antagonists for producing a medicament which extends non-REM sleep and REM sleep.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 3, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 3, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 3, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 3, 2003
GrantedNo grant recorded
Term endedSeptember 3, 2023
Patent numberCA 2501082 A1
Classification (IPC)A61K31/49 +1 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.